Biomarkers Market, by Product Type (Biomarker Test Kits, and Biomarker Analyzers), By Disease Indication (Cancer, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder and Others), by Application (Diagnosis, Drug Discovery and Development, and Others ), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories), and by Geography - Global Forecast to 2025

  • Published On : Apr 2018 |
  • Pages : 187 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Biomarkers Market - Global Industry Insights

Biomarkers are the molecules used for diagnosis of diseases as these indicate normal or abnormal process in the body. Biomarkers can be any molecules such as DNA (genes), proteins or hormones that indicate about the health and can be classified on basis of different parameters, which includes characteristics such as imaging biomarkers or molecular biomarkers. Demand for biomarkers is increasing in drug discovery and development process, as use of biomarkers increases the success rate in drug development process, decrease costs, and improves patient outcome. Biomarkers also aid in predicting drug efficacy, quickly, than conventional clinical endpoints.

Biomarkers are gaining significant traction in product development and treatment of disorders related to chromosome structure, Turner syndrome, Down syndrome, Patau syndrome, Edwards’s syndrome, and others, which is propelling demand for biomarkers. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury, Banyan BTI. Therefore, introduction of such innovative diagnostic tools for various disease indication is projected to fuel growth of the biomarkers market over the forecast period.

Moreover, pharmaceutical companies have started outsourcing the complex bio analysis not only to cut down costs, however, to take advantage of specialized expertise to improve efficiency in drug development process. For instance, in March 2018, the SenzaGen signed a key license agreement with Burlesson Research Technologies, Inc., (BRT)—a contract research organization in the U.S., specializing in immunotoxicology. This agreement, will provide BRTs 'GARD' to a broader market. GARD is a group of tests for assessing chemical sensitizers, where the test uses genetic biomarkers for over 200 genes, which cover an entire immune reaction and are relevant to predicting the risk of hypersensitivity. Such advancement and innovation by CROs is expected to favor growth of biomarkers market in the near future.

The biomarkers market is estimated to be valued at US$ 29,518.2 Mn in 2017 and is expected to witness a robust CAGR of 13.6% during the forecast period (2017-2025).

The Global Biomarkers Market Value (US $ Mn), By Region (2017)

biomarkers market

Source: Coherent Market Insights (2018)

Increasing application of diagnostic application is expected to fuel growth of the global biomarkers market

Increasing application and awareness about biomarker tests is expected to be a major factor for growth of the market. Biomarkers are used for diagnostics and early detection of specific diseases over the conventional diagnostics methods. Furthermore, biomarkers such as BRCA1, indicates whether an individual has an increased likelihood of developing cancer. Biomarkers are also applied to a wide variety of therapeutic areas, which include neurological diseases, metabolic disorders, immune deregulation and oncology to treat various disease such as TMI, cancer, Alzheimer diagnosis. Biomarkers are also used to detect ABO haemolytic disease of new born, Huntington disease, and hereditary haemochromatosis, and cystic fibrosis.

Furthermore, biomarkers are used to detect disorder related to chromosome structure such as, Turner syndrome, Down syndrome, patau syndrome, Edwards’s syndrome, and others, which has led to increasing demand for biomarkers.

Increasing demand for precision medicine to drive the growth of the global biomarkers market

North America accounts for the largest share in the global biomarkers market and this is attributed to adoption of precision medicine and growing prevalence of cancer in the region. According to the National Cancer Institute, 2016, it was estimated that 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from cancer disease. The number of people suffering from cancer is expected to rise to 19 million by 2024, which supports increasing demand for precision medicine.

Furthermore, the U.S. government in 2015 announced the launch of Precision Medicine Initiative that aimed to revolutionize the treatment to improve health, as precision medicine is an innovative approach to offer tailored treatment. Precision Medicine Initiative have led to development of novel drugs and new treatments, tailored for specific characteristic such as person’s genetic makeup or genetic profile of an individual tumor that helps to transform the way of treatment. This also favors growth of the biomarkers market in the near future. As for the development of precision medicine, it is essential to identify biomarkers.

Key players are involved in new product launches to cater to increasing demand for biomarkers. For instance, in 2016 Abbott Laboratories launched Point-of-Care i-STAT Alinity, an innovative, handheld blood testing platform. Some of the other key players in biomarkers market include Medtronic plc, BG Medicine, Inc., F. Hoffmann-La Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.

Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be major factor growth of the market.

Biomarker are required for personalized medicine as it helps to identify the unique characteristics of the disease and helps to tailor medicine according to the need of patients. Hence, to cater to demand for personalized medicines, pharmaceutical companies are investing in R&D, which is expected to lead to identification of novel biomarkers, thus aiding in growth of the market.

Market Dynamics

The global biomarkers market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel biomarker. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury named Banyan BTI. Such innovations, targeting different indications, is expected to drive biomarkers market growth in the near future.

However, investment required for discovering a biomarker is high, due to the cumbersome biomarker validation, and testing process, which hinders growth of the biomarkers market.

Key features of the study:

  • This report provides in-depth analysis of the biomarkers market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Medtronic, BG Medicine, Inc., F. Hoffman LA Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
  • The global biomarkers market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for biomarkers market, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:

  • Global Biomarkers Market, By Product Type:
    • Biomarker Test Kits
    • Biomarker Analyzers
  • Global Biomarkers Market, By Disease Indication:
    • Cancer
    • Cardiovascular Disorder
    • Infectious Disease
    • Neurological Disorder
    • Immunological Disorder
    • Others
  • Global Biomarkers Market, By Application:
    • Diagnosis
    • Drug Discovery and Development
    • Others
  • Global Biomarkers Market, By End User:
    • Hospitals
    • Research Laboratories
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
  • Global Biomarkers Market, By Region:
    • North America
      • North America Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • North America Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • North America Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • North America Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • North America Biomarkers Market, By Country
        • U.S.
        • Canada
    • Europe
      • Europe Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • Europe Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • Europe Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • Europe Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • Europe Biomarkers Market, By Country
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • Asia Pacific Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • Asia Pacific Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • Asia Pacific Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • Asia Pacific Biomarkers Market, By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Latin America Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • Latin America Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • Latin America Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • Latin America Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • Latin America Biomarkers Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Middle East Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • Middle East Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • Middle East Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • Middle East Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • Middle East Biomarkers Market, By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Africa Biomarkers Market, By Disease Indication:
        • Biomarker Test Kits
        • Biomarker Analyzer
      • Africa Biomarkers Market, By Disease Indication:
        • Cancer
        • Cardiovascular Disorder
        • Infectious Disease
        • Neurological Disorder
        • Immunological Disorder
        • Others
      • Africa Biomarkers Market, By Application:
        • Diagnosis
        • Drug Discovery and Development
        • Others
      • Africa Biomarkers Market, By End User
        • Hospitals
        • Research Laboratories
        • Ambulatory Surgical Centers
        • Diagnostic Laboratories
      • Africa Biomarkers Market, By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Abbott Laboratories *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Medtronic
    • BG Medicine, Inc.
    • Hoffman LA Roche Ltd.
    • Seimens Healthnineers
    • Nexus-DX
    • Qiagen N.V.
    • Lifesign LLC

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Epidemiology
    • Biomarker Development Pipeline
    • FDA Biomarker Qualification Program
    • Qualified Biomarker By FDA
    • Reimbursement Scenario
    • PEST Analysis
  4. Global Biomarkers Market, By Product Type, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Biomarker Test Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Biomarker Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  5. Global Biomarkers Market, By Disease Indication, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Cardiovascular Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Infectious Disease 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Neurological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Immunological Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  6. Global Biomarkers Market, By Application, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Diagnosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Drug Discovery and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  7. Global Biomarkers Market, By End User, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Research Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  8. Global Biomarkers Market, By Region, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2016–2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Latin America
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Disease Indication, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Countries, 2015–2025, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BG Medicine, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • F.Hoffman LA Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Seimens Healthnineers
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Nexus-DX
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Qiagen N.V.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Lifesign LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 45 market data tables and 37 figures on "Biomarkers Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.